These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11854072)

  • 1. Comment on: S.S. Prime et al. "A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma" Oral Oncology 2001;37(1), 1-16.
    Patrikidou A; Harris M; Bennett J; Abou-Sleiman P; Delhanty JD
    Oral Oncol; 2002 Feb; 38(2):216-7. PubMed ID: 11854072
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma.
    Prime SS; Thakker NS; Pring M; Guest PG; Paterson IC
    Oral Oncol; 2001 Jan; 37(1):1-16. PubMed ID: 11120478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Association Between oral Squamous cell Carcinoma and Li-Fraumeni Syndrome.
    Dos Santos ES; Santos-Silva AR
    Head Neck Pathol; 2023 Mar; 17(1):277-278. PubMed ID: 36344907
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review.
    Sarode GS; Batra A; Sarode SC; Yerawadekar S; Patil S
    J Contemp Dent Pract; 2016 Jun; 17(6):504-10. PubMed ID: 27484606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefit and burden of cancer screening in Li-Fraumeni syndrome: a case report.
    Jhaveri AP; Bale A; Lovick N; Zuckerman K; Deshpande H; Rath K; Schwartz P; Hofstatter EW
    Yale J Biol Med; 2015 Jun; 88(2):181-5. PubMed ID: 26029016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes.
    Sorscher S; Desnoyers R; Ouyang K; Ramkissoon S
    Oncologist; 2017 Sep; 22(9):1084-1085. PubMed ID: 28592622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "Oral Oncology editorial--Continued misrepresentation of KB cells as being of oral cancer phenotype requires action" [O'Neill ID. Oral Oncol 2009;45(10):e117-118].
    Stokes A
    Oral Oncol; 2010 May; 46(5):e38. PubMed ID: 20338802
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.
    Nemunaitis JM; Nemunaitis J
    Future Oncol; 2008 Dec; 4(6):759-68. PubMed ID: 19086841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts.
    Haque MM; Kowtal P; Sarin R
    Sci Rep; 2018 Aug; 8(1):11705. PubMed ID: 30076369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of the oral cavity.
    Chen AY; Myers JN
    Dis Mon; 2001 Jul; 47(7):275-361. PubMed ID: 11477373
    [No Abstract]   [Full Text] [Related]  

  • 12. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General keynote: hereditary cancer: lessons from Li-Fraumeni syndrome.
    Strong LC
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S4-7; discussion S11-3. PubMed ID: 12586075
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma.
    Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen HA; Toptas B; Hafiz G; Karadeniz A; Isbir T
    In Vivo; 2010; 24(5):755-9. PubMed ID: 20952745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC; Lozano G
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on pediatric cancer predisposition syndromes.
    Schiffman JD; Geller JI; Mundt E; Means A; Means L; Means V
    Pediatr Blood Cancer; 2013 Aug; 60(8):1247-52. PubMed ID: 23625733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial gastric cancer and Li-Fraumeni syndrome.
    Corso G; Pedrazzani C; Marrelli D; Pinto E; Roviello F
    Eur J Cancer Care (Engl); 2010 May; 19(3):377-81. PubMed ID: 19674071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li-Fraumeni syndrome.
    Tabori U; Malkin D
    Cancer Res; 2008 Apr; 68(7):2053-7. PubMed ID: 18381406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of intron 6 sequence variations in the TP53 gene in Li-Fraumeni syndrome.
    Varley JM; McGown G; Thorncroft M; Kelsey AM; Birch JM
    Cancer Genet Cytogenet; 2001 Aug; 129(1):85-7. PubMed ID: 11520573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.